Editorial
doi: 10.1056/NEJMe1109748.
Epub 2011 Aug 27.
A new era for anticoagulation in atrial fibrillation
- PMID: 21870977
- DOI: 10.1056/NEJMe1109748
Item in Clipboard
Editorial
A new era for anticoagulation in atrial fibrillation
N Engl J Med.
.
No abstract available
Comment in
-
Apixaban versus warfarin in atrial fibrillation.N Engl J Med. 2012 Jan 5;366(1):88-9; author reply 89-90. doi: 10.1056/NEJMc1112500. N Engl J Med. 2012. PMID: 22216850 No abstract available.
Comment on
-
Dabigatran versus warfarin in patients with atrial fibrillation.N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. N Engl J Med. 2009. PMID: 19717844 Clinical Trial.
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. N Engl J Med. 2011. PMID: 21830957 Clinical Trial.
-
Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27. N Engl J Med. 2011. PMID: 21870978 Clinical Trial.
Similar articles
-
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?Thromb Haemost. 2011 Apr;105(4):574-8. doi: 10.1160/TH10-12-0808. Epub 2011 Jan 12. Thromb Haemost. 2011. PMID: 21225102 No abstract available.
-
New directions in anticoagulation.Am J Med. 2012 Mar;125(3):217-8. doi: 10.1016/j.amjmed.2011.11.002. Am J Med. 2012. PMID: 22340912 No abstract available.
-
What are the new therapeutic alternatives to warfarin in atrial fibrillation?J Pak Med Assoc. 2013 Jan;63(1):129-30. J Pak Med Assoc. 2013. PMID: 23865151 Review. No abstract available.
-
[New anticoagulants: better knowledge, better prescriptions].Rev Med Suisse. 2012 Jan 18;8(324):96-9. Rev Med Suisse. 2012. PMID: 23185817 French.
-
Novel oral anticoagulants in secondary prevention of stroke.Best Pract Res Clin Haematol. 2013 Jun;26(2):131-9. doi: 10.1016/j.beha.2013.07.007. Epub 2013 Jul 30. Best Pract Res Clin Haematol. 2013. PMID: 23953901 Review.
Cited by
-
Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia.BMC Cardiovasc Disord. 2023 Aug 11;23(1):398. doi: 10.1186/s12872-023-03415-4. BMC Cardiovasc Disord. 2023. PMID: 37568101 Free PMC article.
-
Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database.Clin Drug Investig. 2019 Jul;39(7):665-670. doi: 10.1007/s40261-019-00788-3. Clin Drug Investig. 2019. PMID: 31054085
-
Factors affecting general practitioners' decisions to adopt new prescription drugs - cohort analyses using Australian longitudinal physician survey data.BMC Health Serv Res. 2019 Feb 7;19(1):94. doi: 10.1186/s12913-019-3889-4. BMC Health Serv Res. 2019. PMID: 30728010 Free PMC article.
-
Healthcare Utilization and Expenditures in Working-Age Adults with Atrial Fibrillation: The Effect of Switching from Warfarin to Non-Vitamin K Oral Anticoagulants.Am J Cardiovasc Drugs. 2018 Dec;18(6):513-520. doi: 10.1007/s40256-018-0296-x. Am J Cardiovasc Drugs. 2018. PMID: 30144015 Free PMC article.
-
Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.Pharmacotherapy. 2018 Sep;38(9):907-920. doi: 10.1002/phar.2158. Epub 2018 Jul 26. Pharmacotherapy. 2018. PMID: 29920705 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
